175 related articles for article (PubMed ID: 34588225)
1. Evaluation of amikacin dosing schedule in critically ill elderly patients with different stages of renal dysfunction.
Ghaffari S; Hadi AM; Najmeddin F; Shahrami B; Rouini MR; Najafi A; Mojtahedzadeh M
Eur J Hosp Pharm; 2022 Mar; 29(e1):e67-e71. PubMed ID: 34588225
[TBL] [Abstract][Full Text] [Related]
2. Estimation of once-daily amikacin dose in critically ill adults.
Šíma M; Hartinger J; Cikánková T; Slanař O
J Chemother; 2018 Feb; 30(1):37-43. PubMed ID: 28950787
[TBL] [Abstract][Full Text] [Related]
3. An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration.
D'Arcy DM; Casey E; Gowing CM; Donnelly MB; Corrigan OI
BMC Pharmacol Toxicol; 2012 Nov; 13():14. PubMed ID: 23136834
[TBL] [Abstract][Full Text] [Related]
4. Relationship between hemodynamic and vital support measures and pharmacokinetic variability of amikacin in critically ill patients with sepsis.
Lugo G; Castañeda-Hernández G
Crit Care Med; 1997 May; 25(5):806-11. PubMed ID: 9187600
[TBL] [Abstract][Full Text] [Related]
5. Failure to predict amikacin elimination in critically ill patients with cancer based on the estimated glomerular filtration rate: applying PBPK approach in a therapeutic drug monitoring study.
Telles JP; Diegues MS; Migotto KC; de Souza Borges O; Reghini R; Gavazza BV; Pinto L; Caruso P; E Silva ILF; Schmidt S; de Lima Moreira F
Eur J Clin Pharmacol; 2023 Jul; 79(7):1003-1012. PubMed ID: 37256410
[TBL] [Abstract][Full Text] [Related]
6. Influence of Renal Replacement Modalities on Amikacin Population Pharmacokinetics in Critically Ill Patients on Continuous Renal Replacement Therapy.
Roger C; Wallis SC; Muller L; Saissi G; Lipman J; Lefrant JY; Roberts JA
Antimicrob Agents Chemother; 2016 Aug; 60(8):4901-9. PubMed ID: 27270279
[TBL] [Abstract][Full Text] [Related]
7. Amikacin in Critically Ill Patients: A Review of Population Pharmacokinetic Studies.
Marsot A; Guilhaumou R; Riff C; Blin O
Clin Pharmacokinet; 2017 Feb; 56(2):127-138. PubMed ID: 27324191
[TBL] [Abstract][Full Text] [Related]
8. Population Pharmacokinetic Study of the Suitability of Standard Dosing Regimens of Amikacin in Critically Ill Patients with Open-Abdomen and Negative-Pressure Wound Therapy.
Carrié C; Delzor F; Roure S; Dubuisson V; Petit L; Molimard M; Breilh D; Biais M
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964795
[TBL] [Abstract][Full Text] [Related]
9. Population pharmacokinetic modeling and optimal sampling strategy for Bayesian estimation of amikacin exposure in critically ill septic patients.
Delattre IK; Musuamba FT; Nyberg J; Taccone FS; Laterre PF; Verbeeck RK; Jacobs F; Wallemacq PE
Ther Drug Monit; 2010 Dec; 32(6):749-56. PubMed ID: 20962708
[TBL] [Abstract][Full Text] [Related]
10. Influence of sepsis on higher daily dose of amikacin pharmacokinetics in critically ill patients.
Mahmoudi L; Mohammadpour AH; Ahmadi A; Niknam R; Mojtahedzadeh M
Eur Rev Med Pharmacol Sci; 2013 Feb; 17(3):285-91. PubMed ID: 23426530
[TBL] [Abstract][Full Text] [Related]
11. Relationship between amikacin pharmacokinetics and biological parameters associated with organ dysfunction: a case series study of critically ill patients with intra-abdominal sepsis.
Shahrami B; Sefidani Forough A; Khezrnia SS; Najmeddin F; Arabzadeh AA; Rouini MR; Najafi A; Mojtahedzadeh M
Eur J Hosp Pharm; 2022 Mar; 29(e1):e72-e76. PubMed ID: 34764144
[TBL] [Abstract][Full Text] [Related]
12. High-dose amikacin for achieving serum target levels in critically ill elderly patients.
Sadeghi K; Hamishehkar H; Najmeddin F; Ahmadi A; Hazrati E; Honarmand H; Mojtahedzadeh M
Infect Drug Resist; 2018; 11():223-228. PubMed ID: 29483780
[TBL] [Abstract][Full Text] [Related]
13. Population pharmacokinetics of single-dose amikacin in critically ill patients with suspected ventilator-associated pneumonia.
Burdet C; Pajot O; Couffignal C; Armand-Lefèvre L; Foucrier A; Laouénan C; Wolff M; Massias L; Mentré F
Eur J Clin Pharmacol; 2015 Jan; 71(1):75-83. PubMed ID: 25327505
[TBL] [Abstract][Full Text] [Related]
14. Aminoglycoside Pharmacokinetics in Critically Ill Patients Undergoing Continuous Renal Replacement Therapy.
Krueger CK; Bruno JJ; Tverdek FP; Hernandez M; Abudayyeh A
Ann Pharmacother; 2023 Jun; 57(6):629-636. PubMed ID: 36062536
[TBL] [Abstract][Full Text] [Related]
15. Amikacin Initial Dose in Critically Ill Patients: a Nonparametric Approach To Optimize
Boidin C; Bourguignon L; Cohen S; Roger C; Lefrant JY; Roberts JA; Allaouchiche B; Lepape A; Friggeri A; Goutelle S
Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481443
[TBL] [Abstract][Full Text] [Related]
16. A study of once-daily amikacin with low peak target concentrations in intensive care unit patients: pharmacokinetics and associated outcomes.
Bacopoulou F; Markantonis SL; Pavlou E; Adamidou M
J Crit Care; 2003 Jun; 18(2):107-13. PubMed ID: 12800120
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic of amikacin in critically ill adult and paediatric patients: comparison of once- versus twice-daily dosing regimens.
Marik PE; Havlik I; Monteagudo FS; Lipman J
J Antimicrob Chemother; 1991 May; 27 Suppl C():81-9. PubMed ID: 1856148
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetic dosing of aminoglycosides: a controlled trial.
Bartal C; Danon A; Schlaeffer F; Reisenberg K; Alkan M; Smoliakov R; Sidi A; Almog Y
Am J Med; 2003 Feb; 114(3):194-8. PubMed ID: 12637133
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Amikacin Pharmacokinetics in Critically Ill Patients with Intra-abdominal Sepsis.
Shahrami B; Najmeddin F; Rouini MR; Najafi A; Sadeghi K; Amini S; Khezrnia SS; Sharifnia HR; Mojtahedzadeh M
Adv Pharm Bull; 2020 Jan; 10(1):114-118. PubMed ID: 32002369
[No Abstract] [Full Text] [Related]
20. Population pharmacokinetics of amikacin in critically ill patients.
Bressolle F; Gouby A; Martinez JM; Joubert P; Saissi G; Guillaud R; Gomeni R
Antimicrob Agents Chemother; 1996 Jul; 40(7):1682-9. PubMed ID: 8807062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
